Label-Free Proteomics Study of Alzheimer's Disease MechanismWednesday, 9 November 2011 at 11:15 Add to Calendar ▼2011-11-09 11:15:002011-11-09 12:15:00Europe/LondonLabel-Free Proteomics Study of Alzheimer's Disease MechanismMass Spectrometry Europe in Dublin, IrelandDublin, IrelandSELECTBIOenquiries@selectbiosciences.com Based on the investigation of Alzheimer’s-related blood plasma of 200+ individuals, we concluded that the disease may originate due to a combination of an elevated risk factor and a permissive phenotype. |